Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
VSee HealthVSEE -4.74%8 Debt-to-EBITDA is -0.29 as of Mar. 2026. GuruFocus rates VSEE with a GF Score™ of 8/100. The stock has 5 warning signs investors should review. Among 478 Healthcare Providers & Services companies, VSee Health ranks worse than 209204.81% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for VSee Health's Debt-to-EBITDA or its related term are showing as below:
VSEE'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.36 Med: -0.32 Max: -0.17
Current: -0.25
During the past 5 years, the highest Debt-to-EBITDA Ratio of VSee Health was -0.17. The lowest was -0.36. And the median was -0.32.
VSEE's Debt-to-EBITDA is ranked worse than 100% of 478
companies
in the Healthcare Providers & Services industry
Industry Median: 2.25
vs VSEE: -0.25
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
VSee Health Debt-to-EBITDA Related Terms
VSee Health Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for VSee Health's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VSEE vs MGRX, HCTI, MNDR: Debt-to-EBITDA Comparison
For the Health Information Services subindustry, VSee Health's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
VSee Health Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, VSee Health's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where VSee Health's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
VSee Health (VSEE) has a Debt-to-EBITDA of -0.29 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on VSee Health. According to the industry distribution chart, VSee Health ranks #999999 out of 478 companies in the Healthcare Providers & Services industry.
Is VSee Health's Debt-to-EBITDA too high?
VSee Health's current Debt-to-EBITDA is -0.29. Based on the distribution chart, VSee Health ranks #999999 out of 478 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, VSee Health has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does VSee Health's Debt-to-EBITDA compare to MGRX and HCTI?
According to the Healthcare Providers & Services industry distribution chart, VSee Health ranks #999999 out of 478 companies for Debt-to-EBITDA. This places VSee Health in the lower half of its industry. The industry median Debt-to-EBITDA is 2.25. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.25, based on 478 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on VSee Health. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. VSee Health's current Debt-to-EBITDA is -0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VSee Health stock overvalued right now?
VSee Health (VSEE) has a current Debt-to-EBITDA of -0.29. The current Debt-to-EBITDA is -0.29. VSee Health's overall GF Score™ is 8/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For VSee Health (VSEE), the current Debt-to-EBITDA is -0.29 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
VSee Health Inc is a telehealth software platform offer a comprehensive telehealth platform for U.S. hospitals and enterprises. Through VSee Lab, the company offer a set of telehealth software building blocks, data connectors, and workflow templates that can be rapidly configured into the clients workflows. Companies offerings allow clinicians without programming experience to configure building blocks into their existing workflow without requiring programmers. These set of building blocks can connect to electronic medical record systems such as EPIC and Cerner via HL7, FHIR, and sFTP. The entire telehealth platform sits on a scalable server architecture and is HIPAA compliant and SOC2 externally audited.
8GF Score
Get the complete analysis for VSEE
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VSEE has been successfully added to your 
